Valion Bio Reports Favorable Preclinical Entolimod Safety Results
The company said preclinical study findings support its planned progression to a therapeutic efficacy study.
Related stories
Alliant Energy Reports Third-Quarter Revenue of $1.29 Billion
M impact | EQUITY | Oct 29, 2026, 10:01 PM UTC
Alliant Energy Reports Q3 Pretax Profit of $331 Million
M impact | EQUITY | Oct 29, 2026, 10:01 PM UTC
Twilio Forecasts Slower Q4 Organic Growth Despite Q3 Results Beat
M impact | EQUITY | Oct 29, 2026, 09:55 PM UTC
Amazon Q3 Profit Falls, Stock Down 6%
Amazon reported third-quarter net income of $20.69 billion, or $1.89 per share, compared with $21… a year earlier. Net sales increased 12%; the profit decline reflected the absence
H impact | EQUITY | Oct 29, 2026, 09:52 PM UTC
Starbucks Reports Annual Profit Above Estimates as Turnaround Gains Momentum
M impact | EQUITY | Oct 29, 2026, 09:50 PM UTC
FedEx Freight Holding Company Reports Quarterly Results
FedEx Freight Holding Company reported results for the quarter ended September 30. The supplied text contains no figures.
M impact | EQUITY | Oct 29, 2026, 09:49 PM UTC